4月29日，药明康德早盘上涨5.15%，报61.2港元。公司2025年第一季度营收约96.55亿元，同比增长20.96%；归母净利润36.72亿元，同比增89.06%。截至3月末，公司在手订单达523.3亿元，同比增长47.1%。董事长李革称，预计2025年持续经营业务收入将实现10-15%增长，non-IFRS净利润有望进一步提升。
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.